284 related articles for article (PubMed ID: 25896153)
1. [Changes in Upper Gastrointestinal Diseases according to Improvement of Helicobacter pylori Prevalence Rate in Korea].
Park SH
Korean J Gastroenterol; 2015 Apr; 65(4):199-204. PubMed ID: 25896153
[TBL] [Abstract][Full Text] [Related]
2. Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000.
Nakajima S; Graham DY; Hattori T; Bamba T
Curr Pharm Des; 2000 Oct; 6(15):1503-14. PubMed ID: 10974147
[TBL] [Abstract][Full Text] [Related]
3. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases.
Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K
J Gastroenterol; 2007 Jan; 42 Suppl 17():21-7. PubMed ID: 17238021
[TBL] [Abstract][Full Text] [Related]
4. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; KwiecieĊ S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
5. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
6. Association of Helicobacter pylori with gastroduodenal diseases.
Hirai Y; Hayashi S; Shimomura H; Oguma K; Yokota K
Jpn J Infect Dis; 1999 Oct; 52(5):183-97. PubMed ID: 10680084
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori: beyond peptic ulcer disease.
Wisniewski RM; Peura DA
Gastroenterologist; 1997 Dec; 5(4):295-305. PubMed ID: 9436005
[TBL] [Abstract][Full Text] [Related]
8. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
[TBL] [Abstract][Full Text] [Related]
9. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.
Malfertheiner P; Megraud F; O'Morain C; Bazzoli F; El-Omar E; Graham D; Hunt R; Rokkas T; Vakil N; Kuipers EJ
Gut; 2007 Jun; 56(6):772-81. PubMed ID: 17170018
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori in solid-organ transplant recipient.
Ueda Y; Chiba T
Curr Opin Organ Transplant; 2008 Dec; 13(6):586-91. PubMed ID: 19060547
[TBL] [Abstract][Full Text] [Related]
11. Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years.
Nakajima S; Nishiyama Y; Yamaoka M; Yasuoka T; Cho E
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S99-S110. PubMed ID: 20586876
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Helicobacter pylori infections.
Thijs JC; Kuipers EJ; van Zwet AA; Pena AS; de Graaff J
QJM; 1995 Jun; 88(6):369-89. PubMed ID: 7648229
[TBL] [Abstract][Full Text] [Related]
13. [Helicobacter pylori-related diseases: dyspepsia, ulcers and gastric cancer].
Gisbert JP
Gastroenterol Hepatol; 2011 Oct; 34 Suppl 2():15-26. PubMed ID: 22330153
[TBL] [Abstract][Full Text] [Related]
14. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.
Huang JQ; Sridhar S; Hunt RH
Lancet; 2002 Jan; 359(9300):14-22. PubMed ID: 11809181
[TBL] [Abstract][Full Text] [Related]
15. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
18. [Peptic Ulcer Disease Associated with Helicobacter pylori Infection].
Yeo SH; Yang CH
Korean J Gastroenterol; 2016 Jun; 67(6):289-99. PubMed ID: 27312829
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori and non-malignant upper gastrointestinal diseases.
Vasapolli R; Malfertheiner P; Kandulski A
Helicobacter; 2016 Sep; 21 Suppl 1():30-3. PubMed ID: 27531536
[TBL] [Abstract][Full Text] [Related]
20. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX
Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
